| Events by Stage and Age Group | |||||
| ER+ and TNBC subgroup analytic samples | |||||
| Stage | Age group | N | Events | Censored | Event % |
|---|---|---|---|---|---|
| ER+ | |||||
| Stage 1 | <50 | 74 | 8 | 66 | 10.8 |
| Stage 1 | 50-64 | 90 | 20 | 70 | 22.2 |
| Stage 1 | 65+ | 57 | 27 | 30 | 47.4 |
| Stage 2 | <50 | 150 | 33 | 117 | 22.0 |
| Stage 2 | 50-64 | 82 | 27 | 55 | 32.9 |
| Stage 2 | 65+ | 35 | 11 | 24 | 31.4 |
| Stage 3 | <50 | 49 | 31 | 18 | 63.3 |
| Stage 3 | 50-64 | 38 | 23 | 15 | 60.5 |
| Stage 3 | 65+ | 9 | 6 | 3 | 66.7 |
| TNBC | |||||
| Stage 1 | <50 | 27 | 5 | 22 | 18.5 |
| Stage 1 | 50-64 | 26 | 8 | 18 | 30.8 |
| Stage 1 | 65+ | 17 | 8 | 9 | 47.1 |
| Stage 2 | <50 | 107 | 26 | 81 | 24.3 |
| Stage 2 | 50-64 | 60 | 21 | 39 | 35.0 |
| Stage 2 | 65+ | 11 | 7 | 4 | 63.6 |
| Stage 3 | <50 | 38 | 22 | 16 | 57.9 |
| Stage 3 | 50-64 | 12 | 7 | 5 | 58.3 |
| Stage 3 | 65+ | 5 | 5 | 0 | 100.0 |
| Age groups: <50, 50–64, and 65+. Events reflect the recurrence-free survival event indicator used in the Cox models. | |||||